Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clement L Ren

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
International Journal of Neonatal Screening|July 27, 2022
Newborn Screening for Cystic Fibrosis: A Qualitative Study of Successes and Challenges from Universal Screening in the United StatesMarci K Sontag, Joshua I Miller, Sarah McKasson, et al.
Annals of the American Thoracic Society|April 25, 2026
Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor (ETI) in People with Cystic Fibrosis in the United StatesGeorgene E Hergenroeder, Jonathan V Todd, Josh S Ostrenga, et al.
Annals of the American Thoracic Society|December 31, 2014
ATS core curriculum 2014: part IV. Pediatric pulmonary medicineMary A Nevin, Cori L Daines, Gregory J Redding, et al.
Pediatric Pulmonology|November 15, 2011
Analysis of the associations between lung function and clinical features in preschool children with cystic fibrosisClement L Ren, Margaret Rosenfeld, Oscar H Mayer, et al.
Pediatric Pulmonology|November 15, 2021
Pulmonary function tests in extremely low gestational age infants at one year of ageJudith A Voynow, Rui Feng, Clement L Ren, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 9, 2021
Magnetic resonance imaging of cystic fibrosis: Multi-organ imaging in the age of CFTR modulator therapiesKimberly McBennett, Christina J MacAskill, Elise Keshock, et al.
Annals of the American Thoracic Society|January 18, 2018
Cystic Fibrosis Foundation Pulmonary Guidelines. Use of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy in Patients with Cystic FibrosisClement L Ren, Rebecca L Morgan, Christopher Oermann, et al.
Pediatric Pulmonology|May 2, 2024
Lung T1 MRI assessments in children with mild cystic fibrosis lung diseaseClement L Ren, Samya Z Nasr, James E Slaven, et al.
Pediatric Pulmonology|July 3, 2010
Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohortMargaret Rosenfeld, Julia Emerson, Sharon McNamara, et al.
Pediatric Pulmonology|April 20, 2026
Lung T1-MRI and Multi-Breath Washout Detect Longitudinal Changes in Children 6-11 Years Old After Beginning Elexacaftor/Tezacaftor/Ivacaftor (ETI) TherapySamya Z Nasr, Chris A Flask, Madison E Kretzler, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
International Journal of Neonatal Screening|July 27, 2022
Newborn Screening for Cystic Fibrosis: A Qualitative Study of Successes and Challenges from Universal Screening in the United StatesMarci K Sontag, Joshua I Miller, Sarah McKasson, et al.
Annals of the American Thoracic Society|April 25, 2026
Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor (ETI) in People with Cystic Fibrosis in the United StatesGeorgene E Hergenroeder, Jonathan V Todd, Josh S Ostrenga, et al.
Annals of the American Thoracic Society|December 31, 2014
ATS core curriculum 2014: part IV. Pediatric pulmonary medicineMary A Nevin, Cori L Daines, Gregory J Redding, et al.
Pediatric Pulmonology|November 15, 2011
Analysis of the associations between lung function and clinical features in preschool children with cystic fibrosisClement L Ren, Margaret Rosenfeld, Oscar H Mayer, et al.
Pediatric Pulmonology|November 15, 2021
Pulmonary function tests in extremely low gestational age infants at one year of ageJudith A Voynow, Rui Feng, Clement L Ren, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 9, 2021
Magnetic resonance imaging of cystic fibrosis: Multi-organ imaging in the age of CFTR modulator therapiesKimberly McBennett, Christina J MacAskill, Elise Keshock, et al.
Annals of the American Thoracic Society|January 18, 2018
Cystic Fibrosis Foundation Pulmonary Guidelines. Use of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy in Patients with Cystic FibrosisClement L Ren, Rebecca L Morgan, Christopher Oermann, et al.
Pediatric Pulmonology|May 2, 2024
Lung T1 MRI assessments in children with mild cystic fibrosis lung diseaseClement L Ren, Samya Z Nasr, James E Slaven, et al.
Pediatric Pulmonology|July 3, 2010
Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohortMargaret Rosenfeld, Julia Emerson, Sharon McNamara, et al.
Pediatric Pulmonology|April 20, 2026
Lung T1-MRI and Multi-Breath Washout Detect Longitudinal Changes in Children 6-11 Years Old After Beginning Elexacaftor/Tezacaftor/Ivacaftor (ETI) TherapySamya Z Nasr, Chris A Flask, Madison E Kretzler, et al.
Pageof 13